Results 241 to 250 of about 2,408,361 (302)
A weakly supervised transformer for rare disease diagnosis and subphenotyping from EHRs with pulmonary case studies. [PDF]
Greco KF +8 more
europepmc +1 more source
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Smartphone apps in rare disease care: a Dutch perspective on effective implementation. [PDF]
Willemse IHJ +4 more
europepmc +1 more source
Objective This research article aims to describe the prevalence, associations and health‐related quality‐of‐life (HRQoL) impact of mucocutaneous features of SLE. Methods Data from the Asia‐Pacific Lupus Collaboration cohort were analysed (2013‐2021). Mucocutaneous activity (MC‐A) items were rash, alopecia and mucosal ulcers; defined by the SLEDAI‐2K ...
Amanda M Saracino +42 more
wiley +1 more source
Importance and Potential of Rare Disease Research in Pediatric Rheumatology and Beyond: Pushing Frontiers. [PDF]
Hedrich CM.
europepmc +1 more source
Objective Cam morphology, a significant risk factor for hip osteoarthritis, is commonly quantified by the alpha angle (AA). This study aims to explore the potential of the triangular index ratio (TIR) to quantify cam morphology on anteroposterior radiographs by assessing the association between TIR‐defined cam morphology and the development of ...
Jinchi Tang +7 more
wiley +1 more source
Advances in Cell and Gene Therapy for Rare Disease Treatment. [PDF]
Baek HJ, Nam Y, Rim YA, Ju JH.
europepmc +1 more source
Consumed by Abdominal Distention
Arthritis Care &Research, EarlyView.
Abimbola Fadairo‐Azinge +3 more
wiley +1 more source
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Schimke immunoosseous dysplasia (SIOD): Delayed onset of rare disease and novel variant. [PDF]
Elshirbeny M +3 more
europepmc +1 more source

